MILLICENT MINOR: Open Payments
NPI 1285223420 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,706 in 147 payments from 24 companies in 2025. Trend: 2023 $2,250 · 2024 $4,450 · 2025 $5,706
Food & beverage: $4,474Consulting: $1,125Education: $107
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $1,644 |
| UCB, Inc. | 20 | $595 |
| Arcutis Biotherapeutics, Inc. | 18 | $543 |
| ABBVIE INC. | 21 | $445 |
| Incyte Corporation | 4 | $359 |
| GENZYME CORPORATION | 8 | $356 |
| Regeneron Healthcare Solutions, Inc. | 11 | $211 |
| Novartis Pharmaceuticals Corporation | 10 | $210 |
| Amgen Inc. | 6 | $199 |
| Galderma Laboratories, L.P. | 5 | $195 |
Products named: TREMFYA, Bimzelx, Zoryve, DUPIXENT, SKYRIZI, Opzelura, OTEZLA, NEMLUVIO.
Industry payments across FL — which companies pay providers there.
